Cardea secures international patent coverage for its pioneering work on developing mass-produced graphene biosensors

/PRNewswire/ -- Today, Cardea Bio, Inc. - the world's first mass producer of graphene biosensors - shares their continued success to secure broad intellectual...

Related Keywords

Albania ,Latvia ,Serbia ,Malta ,United States ,United Kingdom ,China ,San Marino ,Portugal ,Czech Republic ,Austria ,San Diego ,California ,Iceland ,Netherlands ,Italy ,Finland ,Ireland ,South Korea ,Poland ,Switzerland ,Spain ,Monaco ,Greece ,Norway ,Japan ,Macedonia ,Luxembourg ,Liechtenstein ,Canada ,Germany ,Estonia ,Denmark ,Hungary ,Croatia ,Slovenia ,Belgium ,Sweden ,Bulgaria ,Lithuania ,Cyprus ,France ,Turkey ,Romania ,America ,American ,Los Angeles ,Brett Goldsmith ,Siemens Healthineers ,Michael Heltzen ,Cardea Bio ,Rangarajan Sampath ,Siemens ,Head Of The Center ,Field Effect Transistors ,Biosignal Processing Unit ,Chief Technology Officer ,Senior Vice President ,Innovation Partnerships ,North Macedonia ,